News Releases 2023
-
Business
Notification of Application for Additional Dosage Form of SGLT2 inhibitor CANAGLU® OD Tablets 100 mg
NEW
-
Business
Study on the World's First Commercialization of Polycarbonate Resin Chemical Recycling
NEW -
Business
Plant-derived Bio-engineering Plastic "DURABIO" Adopted for Ballpoint Pen of Design Stationery Brand "ZOOM"NEW
-
Business
The Mitsubishi Chemical Group announces the Winners of the Composite Engineering Challenge
-The jury team chose Herone from Germany as the Overall Winner and Project Unlimited from the Netherlands as the Innovation Award Winner- -
Personnel
Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group
-
Business
Plant-derived Bioengineering Plastic "DURABIO" Acquires Two Bio-based Product Certifications in Europe
-
Business
Notice regarding Specific Action Plan and Update of Performance Targets related to Management Policy "Forging the future"
-
Business
Announcement of Winning the 5th Japan Open Innovation Prize "Minister of Environment Award"
"Practical Use of Environmentally Friendly Biomass-based Plastic for Blister Packages" -
Business
Acquisition of International Sustainability and Carbon Certification “ISCC PLUS Certification”
-
Business
Establishment of Japan’s First Acrylic Resin Collection Scheme in Collaboration with Tokio Marine & Nichido and ABT
—Verification testing for the commercialization of molecular recycling will begin—
-
Others
Mitsubishi Chemical Group Earned “Top 10% S&P Global ESG Score 2022” in S&P Global's Sustainability Rating
-
Financial Results
Notice on Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
-
Others
Notice of Award for the Arbitration Filed against Mitsubishi Tanabe Pharma Corporation, a Consolidated Subsidiary
-
Business
Discontinuation of the Development of a Regenerative Medicine Product (CL2020) Using Muse Cells
-
Business
Announcement on Winning the 5th Japan Open Innovation Prize
—Becoming a Double Winner for Achieving Practical Use of Plant-based Medicinal Product Packages and Verification Testing on an Organic Recycling System for Paper Cups Made from Compostable Polymer
-
Business
A joint paper on “a new computational method for energy calculations of photonic materials on quantum computers” was published in a Nature Research Journal
～Development of variational quantum eigensolver with spin-restricted ansätze and automatically-adjusted constraints (VQE/AC method)～
-
Business
Making Light Benches by Combining Transparent and Highly Durable Bio-based Plastic (DURABIO) with Large-scale Textured 3D Printing
—Developing a New Method to Create Outdoor Spaces -
Financial Results
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2023
-
Financial Results
Earnings Impact due to Cessation of MMA-related Product Production at Mitsubishi Chemical UK Limited and Revision to Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023
-
Others
Notice on Absorption-type Merger of a Wholly-owned Subsidiary (Simplified Merger and Short-form Merger)
-
Others
Merger of Mitsubishi Chemical Systems Inc.
-
Business
Overseas Consolidated Subsidiary, Medicago to Cease Operations
-
Business
Enhancement of Production Capacity for Specialty Brands of Polyvinyl Alcohol Resin GOHSENX and Nichigo G-Polymer
-
Business
The Mitsubishi Chemical Group, Mitsui Chemicals Launch Study Into Joint Logistics
～Aiming to standardize and optimize chemical logistics through the use of DX～ -
Others
New Group Concept (Purpose, Slogan, Our Way)
-
Others
Newsletter Vol. 2: The Mitsubishi Chemical Group's Circular Economy Initiatives
Prospects for Building a Sustainable Recycling System -
Personnel
Announcement of Personnel Changes of the Mitsubishi Chemical Group
-
Personnel
Notice Regarding Changes in Representative Corporate Executive Officer
-
Business
Announcing the winners of the 16th Soalon Design Contest
Contest on designs using plant-derived semi-synthetic fiber held at Bunka Gakuen University -
Business
Announcement of Positive Results from the Phase 3 Clinical Trials of Parkinson's Disease Drug Candidate ND0612
-
Others
New Year Message from President and CEO, Jean-Marc Gilson
